Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
3
×
life sciences
national blog main
boston
boston top stories
clinical trials
national top stories
new york blog main
new york top stories
alnylam pharmaceuticals
amgen
andrew berens
avapritinib
azacitidine
beta-thalassemia
biotech
blueprint medicines
cancer
cholesterol
dacogen
deals
deciphera pharmaceuticals
decitabine
dna
epigenetics
epizyme
farydak
flagship pioneering
fulcrum therapeutics
gastrointestinal stromal tumor
gist
gleevec
imatinib
inclisiran
insulated genomic domains
kaleido biosciences
mahesh karande
new york
omega therapeutics
panobinostat
What
morning
3
×
drug
fda
filing
medicines
touting
aims
announced
approach
approval
based
biotech
blueprint
bringing
called
cancer
chasing
cholesterol
clears
closer
deadly
debuts
deciphera
developing
drugs
epigenetic
epigenetics
field
flagship’s
forms
gi
inched
lowering
market
medco
medicine
new
omega
pharamceuticals
phase
Language
unset
3
×
Current search:
morning
×
unset
×
" boston blog main "
×
@xconomy.com
4 years ago
MedCo Preps for FDA Filing as Cholesterol Drug Clears Last Two Tests
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
4 years ago
Chasing Blueprint, Deciphera Plans FDA Filing for GI Cancer Drug